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Abstract 
 
The cytoskeleton is the major intracellular structure that determines the morphology of 
neurons and maintains their structural integrity. It is therefore not surprising that a 
disturbance of cytoskeletal structure and function underlies many neurodegenerative 
diseases. This special issue brings together current information on the three major 
neuronal cytoskeletal filament systems, microtubules, microfilaments and 
neurofilaments, and aims to provide a comprehensive overview of the role of the key 
components of these three systems under both physiological and pathological 
conditions. It therefore also addresses the role of microtubule-associated proteins (with 
a focus on tau) and motor proteins (with a focus on kinesin). 
 
 
Main text 
 
The cytoskeleton is a key component of every eukaryotic cell. It consists of protein 
polymers and a collection of associated factors that are organized in a network of 
filamentous arrays that interact in a dynamic manner. The cytoskeleton provides a 
structure that, on the one hand, is rigid, and on the other hand is responsive to a range 
of cues which allow it to be sufficiently plastic to facilitate a change in cell shape and, 
in some cases, cell movement. The cytoskeletal elements also interact with motor 
proteins that provide both the force and directionality that are needed for intracellular 
transport and mobility (Tuszynski et al., 2003). 
 In neurons, the cytoskeleton is tailored to meet the specific needs of this 
specialized cell type, which consists of a cell soma and two principal types of processes, 
the axons and the dendrites, which can extend a remarkable distance from the soma and 
develop a complex branching pattern depending on the type of neuron. The axon is 
separated from the soma by the axon initial segment, which provides an effective 
diffusion barrier. Dendrites are further compartmentalized based on the presence of 
dendritic spines that represent the post-synaptic compartment of most excitatory input. 
The dendrites and the soma comprise a relay station where incoming signals are 
integrated. Neurons maintain their peculiar structure and compartmentalization with the 
help of an internal dynamic cytoskeleton made up of different filament systems. The 
three main neuronal cytoskeletal structures discussed in this Special Issue are actin 
filaments (Nixon, Gallo), neurofilaments (Vickers) and microtubules (Baas, Gallo, 
Prokop). Associated with microtubules, and binding to them, are microtubule-
associated proteins (MAPs), including the axonal protein tau (Arendt), and motor 
proteins, such as kinesin, which provides anterograde transport, and dynein, a 
retrograde transporter (Kins). Prominent proteins that interact with actin filaments and 
are considered to regulate microfilament structure are the tropomyosins (Fath) and 
drebrin (Gordon-Weeks).  
 A plethora of articles are available on selective aspects of cytoskeletal proteins 
but what has been lacking from the literature is a collection of review articles focusing 
on all of these major cytoskeletal elements and the proteins with which they are 
associated, as well as their function in health and disease. This Special Issue brings 
together nine review articles that present information on the role of the neuronal 
cytoskeleton under both physiological and pathological conditions, its interactions and 
its regulation, as detailed below. 
 (1) Microtubules serve as structural elements to allow axons and dendrites to 
obtain their specialized morphology. They also function as long-distance railways for 
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the anterograde and retrograde transport of proteins and organelles. Peter Baas and 
Andrew Matamoros discuss the intricacies of microtubule dynamics and outline how 
the nucleation of microtubules occurs as well as the way in which the three forms of 
tubulin (, , and ) differ (Baas). Microtubules are intrinsically polar structures, with 
-tubulin being located at the plus and -tubulin at the minus end; the motor dynein 
moves towards the minus end of the microtubule and most kinesins move towards the 
plus end. Facilitating microtubule organization in neurons, microtubule-interacting 
proteins are enriched in specific compartments, such as TRIM46 in the axon initial 
segment. The authors also discuss the puzzle regarding the source of neuronal 
microtubule stability. Although tau and other MAPs are traditionally seen as 
microtubule-stabilizing compounds, it is suggested (factoring in the millisecond on and 
off rate of these proteins) that they may be more important in regulating rather than 
conferring stability. Attention is also given to microtubule end-targeting proteins (such 
as EB3) and microtubule-severing proteins (katanin and spastin). Regarding motor 
proteins, the concept of a specific tubulin code, which seems to mark microtubules for 
defined interactions, is discussed. The final section of this review then discusses 
microtubule dysfunction in the context of disease (Alzheimer's disease, amyotrophic 
lateral sclerosis and Huntington's disease). The authors suggest that, rather than 
exploring the potential of microtubule-stabilizing drugs, inhibiting microtubule-
severing proteins might be the better approach for therapeutic interventions targeting 
microtubules. 
 (2) Andreas Prokop and colleagues specifically discuss the dynamics of 
microtubules, dissecting the cytoskeletal machinery into its conceptual sub-machineries 
and then assessing how these interface with each other (Prokop). The first section of 
this review addresses the role of microtubule dynamics in development and how this 
dynamic feature persists into adulthood. The second section provides an overview of 
the physical and biochemical properties of tubulin and how microtubules, the stiffest of 
all cytoskeletal polymers, form lattices. The various mechanisms regulating the 
dynamics of microtubules at the plus end are discussed and summarized in an 
integrating figure, highlighting the importance of how tubulin pools are controlled in 
axons. The article discusses this issue, delving into the transcriptional control of 
tubulin, the different modes of transport, microtubule stability and controlled 
degradation pathways. Up to a few hundred EB proteins can bind to the microtubule 
plus end with a very short dwell time, i.e. in a highly dynamic manner with a constant 
turn-over. These interactions are discussed, together with the various functions of the 
plus end. Finally, a section also addresses the influence of lattice-based mechanisms on 
the polymerization and depolymerization  of microtubules, and reports on the post-
translational modifications of microtubules that are often taken as indicators of 
microtubule stability, with detyrosination and acetylation correlating with stable 
fractions. As is also discussed by Matamoros and Baas (Baas), the mechanism by which 
MAPs act on microtubules is poorly understood. Prokop and colleagues present a model 
in which microtubules in mature axons are constantly renewed through steady state 
de/polymerization processes. 
 (3) Thomas Arendt and colleagues present a comprehensive overview of the 
'neuronal' MAP tau, broadly covering its cell biology and central role in tauopathies 
including Alzheimer's disease (Arendt). The cell biology section covers tau haplotypes 
and the regulation of gene expression of this multiple isoform protein, providing 
structural insight into tau and its domains, its post-translational modification, with a 
major focus on phosphorylation, and its cellular functions (canonical in binding 
microtubules, non-canonical, and even non-neuronal). The second half of the review 
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discusses all facets of tau pathology, initially focusing on Alzheimer's disease as 'the' 
tauopathy prototype, and then on tauopathies more generally, in which the tau 
pathology is not confined to neurons, but is also present in glial cells. The review 
contains 12 figures that are suitable for didactic purposes and four detailed tables, 
listing tau phosphorylation sites, the various tauopathies, a classification of tauopathies 
based on the predominant tau isoform, and the predominant cell-type-specific tau 
pathology in different tauopathies. In their conclusion, Arendt and colleagues point out 
that our appreciation of the role of tau in 'non-typical' compartments, such as the 
nucleus and spines, is only slowly unfolding. Furthermore, as they point out, how tau 
causes neurodegeneration is still not well understood. Another intriguing question is 
the biological significance of the large heterogeneity of tau isoforms, with tau being an 
apparently promiscuous molecule. Finally, determining how the two key lesions of 
Alzheimer's disease, tau and amyloid  (A), interact, is important for developing 
treatment strategies, yet there is a still a lack of basic understanding in relation to this 
issue. 
 (4) In his review, Phillip Gordon-Weeks discusses the filamentous (F)-actin 
side-binding and bundling protein drebrin, which couples actin filaments to dynamic 
microtubules (Gordon-Weeks). This interaction has a critical developmental role 
during neuronal growth cone formation, as well as in the dendritic spines of mature 
neurons. As elaborated in the article, drebrin comes in two forms, an 'embryonic' 
drebrin E and an 'adult' drebrin A; however, their distinctive roles have not been fully 
dissected. The author suggests the use of super-resolution microscopy to better 
understand how drebrin is distributed in neurons and what governs its localization. He 
further discusses the various binding partners of drebrin, together with the functional 
domains in the protein that govern these interactions. A preferred partner of drebrin is 
EB3 that localizes to the growing plus end of dynamic microtubules. Evidence from 
cell biological studies and structural analyses are presented that indicate that drebrin 
stabilizes F-actin. In the case of spines, it is well known that the dynamic behaviour of 
F-actin and microtubules dominates dendritic spine changes in response to synaptic 
activity. Here, drebrin has an important role, influencing dendritic spine morphology 
by regulating F-actin, facilitating the activity-dependent accumulation of the 
scaffolding protein PSD-95 in the post-synaptic density, and distributing NMDA 
receptors. An interesting discussion is presented that focuses on activity-driven 
microtubule capture and insertion into dendritic spines. Whereas normally only 
approximately 1% of dendritic protrusions contain a microtubule at any time, the 
frequency of invasion, as well as the dwell time, are enhanced by activation, with EB3 
being localized to the tip of these microtubules. In a disease context, drebrin loss, 
concomitant with an increase in the actin-severing factor cofilin, has been shown to 
precede synaptic loss in Alzheimer's disease. Drebrin loss can also be induced in vitro 
by incubation with A oligomers. Cofilin activity is negatively regulated by the activity 
of LIM kinase that, interestingly, protects against A-induced drebrin loss. As 
suggested, more work needs to be undertaken to investigate the drebrin/EB3 pathway, 
or any other pathway, that links dynamic microtubules and F-actin under physiological 
or pathological conditions. 
 (5) Next, Gianluca Gallo and Ammudena Pacheco review the literature covering 
recent advances in our understanding of cytoskeletal interactions in neurons by 
focusing on the initiation of processes from neuronal cell bodies and the collateral 
branching of axons (Gallo). The authors come to the conclusion that the appreciation 
of the neuron as an integrated system remains a frontier of investigation. The review 
discusses differences in nucleation mechanisms that are more restricted for 
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microtubules than for actin, with the majority of work being done in vitro. The authors 
discuss the evidence for cross-talk and interactions between actin filaments and 
microtubules in the growth cone and in axon branching and initiation, presenting the 
data in a historical overview. There is a section on MAPs, with the different forms of 
MAP2 and MAP1b all binding to both microtubules and actin. The fourth section 
discusses microtubule plus end-associated proteins (EB proteins, drebrin, CLIP-170, 
cytoplasmic linker protein-associated proteins (CLASPs), spectraplakins, neuron 
navigator 1 (NAV1) and adenomatous polyposis coli (APC)), after which additional 
regulators of cytoskeletal cross-talk and organization (septins, collapsin response 
mediator proteins (CRMPs) and doublecortin) are considered. The review then finishes 
with a mechanistic section on how microtubules are targeted into filopodia. The authors 
conclude that, in order to fully understand the complexity of cytoskeletal cross-
regulation, the full spectrum of interactions and interactors needs to be addressed in 
space and time during the multiple steps in the formation of processes and collateral 
branches. Given that the cytoskeleton underlies neuronal biomechanics, they also 
suggest that pioneering studies are required to address the biomechanics of axon 
initiation and branching.     
 (6) Thomas Fath and colleagues write about the role of tropomyosins in the 
healthy and diseased nervous system (Fath). Their review first provides a general 
overview of tropomyosins, for which more than 40 isoforms are known. Tropomyosins 
are a family of actin-associated proteins, initially identified in muscle, that play a major 
role in the regulation of the actin cytoskeleton. The major neuronal isoforms are Tpm1, 
Tpm3 and Tpm4, although their function is not fully understood. For each major 
isoform, multiple variants are known, adding to the complexity of this protein family. 
The authors then discuss the role of tropomyosins in neurite outgrowth and at neuronal 
synapses. There is a cross-talk of different actin regulating proteins; for example, 
members of the actin filament-severing protein family ADF/cofilin compete with 
tropomyosins for actin binding, whereas tropomyosin sorting is regulated by formins, 
a class of potent actin filament nucleators. A section in the review is dedicated to the 
role of tropomyosins in nervous system disorders, such as Alzheimer's disease, 
Parkinson's disease, amyotrophic lateral sclerosis and schizophrenia, as well as in spinal 
cord injury and traumatic brain injury. The review concludes by discussing 
tropomyosins as potential mediators and targets in neuronal repair. The authors suggest 
that because the interaction of tropomyosins with actin-binding proteins and actin itself 
is isoform-dependent, these isoforms represent excellent specific targets for therapeutic 
intervention. 
 (7) James Vickers and colleagues discuss the third major group of neuronal 
cytoskeletal structures, neurofilaments, which have not been demonstrated to play a 
role in the initiation or branching of axons (Vickers). This review is mainly focused on 
disease. Acknowledging that abnormalities of the neuronal cytoskeleton are frequently 
a key feature of neurodegenerative diseases, in particular Alzheimer's disease, the 
authors identify several knowledge gaps, such as those related to the biochemical and 
histological characterization of changes that have been identified ultrastructurally. 
They present a historical discourse on the development of staining techniques for the 
cytoskeleton, with the silver impregnation methods of Bielschowsky and Bodian 
having the greatest affinity for the neurofilament triplet NFL, NFM and NFH, whereas 
the closely related Gallyas and Campbell-Switzer methods are routinely used to 
visualize the two Alzheimer's lesions, tau-containing neurofibrillary tangles and A-
containing amyloid plaques. Interestingly, tangles were originally, but incorrectly, 
thought to be composed of neurofilaments; however, as discussed, some neurofilament 
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epitopes may lie buried within the filament structure of the tangles. Vickers and 
colleagues discuss the structure and polymerization of neurofilaments, and expand on 
the interaction of these proteins with other cytoskeletal elements, including actin, 
myosin and plectins, as well as MAPs and motor proteins. A section has been included 
to discuss the susceptibility of neuronal subsets in neurofibrillary pathology and the 
associated involvement of neurofilaments, together with the role of A in inducing 
dystrophic changes. This leads the authors to conclude that neurofilaments have an 
important role in the susceptibility of neurons to key cytoskeletal changes in 
Alzheimer's disease. 
 (8) Ralph Nixon and Aidong Yuan also focus on neurofilaments, in particular 
their role in synapses, where neurofilaments form distinctive assemblies (Nixon). They 
refer to data showing that the triplet proteins and the neurofilament protein -internexin 
are all abundant in fractions obtained from the post-synaptic density, and that they 
interact with various synaptic proteins, including SAPAP and spinophilin, as well as 
tau. A section is dedicated to the neurofilament subunit-specific modulation of synaptic 
functions and behaviours. Here, NFL has been shown to interact not only with NMDA 
receptors, but also with the adaptor protein 14-3-3 and protein phosphatase 1 (PP1). 
NFM, in contrast, specifically interacts with dopamine receptors, as shown for synaptic 
boutons, whereas  NFH has a role in long-term potentiation. Ralph Nixon and Aidong 
Yuan move on to discuss alterations of neurofilament proteins in psychiatric disorders, 
starting with schizophrenia and bipolar disorder, and then discussing the role of distinct 
neurofilament proteins in drug addiction. In their discussion of Alzheimer's disease, 
they make the point that neurofibrillary tangles contain not only tau, but also 
neurofilaments, vimentin and different forms of MAPs, with a variable degree of 
phosphorylation. They finish their review by introducing an only recently described 
disease, neurofilament inclusion disease (NFID), that clinically resembles 
frontotemporal dementia. They conclude that, although synaptic dysfunction 
characterizes major neuropsychiatric disorders, the dynamics of cytoskeletal proteins 
at synaptic terminals is not really understood, particularly in the case of neurofilaments. 
These intermediate filaments have unique space-filling properties that facilitate their 
well-established role in calibre expansion of myelinated axons, a critical feature of 
effective nerve conduction. However, as also discussed in this review, there is growing 
evidence that neurofilaments in the central nervous system have important functions 
that go beyond calibre expansion. 
 (9) In the final article of this series, Stefan Kins, Gerardo Morfini and colleagues 
focus on conventional kinesin, the most abundant kinesin-related motor protein in the 
mature nervous system (Kins). After introducing axonal transport in general, and the 
role of microtubules more specifically, they introduce the kinesin superfamily of motor 
proteins (KIFs) which is classified into 15 subfamilies. A presentation of the subunit 
composition, structural diversity and domain structure of conventional kinesin is 
followed by a section on the mode of kinesin attachment to membrane-bound organelle 
cargoes. Although no 'bona fide' receptors have been identified, and the mode of 
attachment of conventional kinesin to its cargoes therefore remains a mystery, several 
adaptors are known to bind either the heavy or the light chain of the kinesin 
heterotetrameric complex. This is discussed, followed by an assessment of the role of 
the different kinesin variants. The authors imply the existence of regulatory 
mechanisms for the localized delivery of cargoes, considering that there can be up to 
thousands of presynaptic terminals as 'delivery addresses'. The final section of the 
article addresses the role of impaired axonal transport in neurodegenerative disease, 
with a role of pathogenic forms of tau and A known to inhibit conventional kinesin-
 7 
based axonal transport. Here, specific kinases have been found to have a role; however, 
as the authors state, it remains an open question whether kinase-mediated axonal 
transport deficits represent a primary event in the course of neurodegenerative disease 
or, alternatively, an epiphenomenon.  
 
Outlook 
 
Gurel and colleagues (Gurel et al., 2014) recently captured what is needed in this 
rapidly advancing field, writing that 'a tendency in cell biology is to divide and conquer. 
For example, decades of painstaking work have led to an understanding of endoplasmic 
reticulum and Golgi structure, dynamics, and transport. In parallel, cytoskeletal 
researchers have revealed a fantastic diversity of structure and cellular function in both 
actin and microtubules. Increasingly, these areas overlap, necessitating an 
understanding of both organelle and cytoskeletal biology.' 
Not surprisingly, several of the nine review articles in this Special Issue address the 
interaction of cytoskeletal proteins, most prominently actin and microtubules, in 
mediating cellular functions. With the unique features of neurons and their 
compartmentalization, there will undoubtedly be an increased interest in understanding 
the role of the cytoskeleton at the site at which action potentials are initiated, as well as 
at the synapse where neurons communicate. With the advent of super-resolution 
microscopy techniques, it should now be possible to obtain a deeper understanding of 
where and how the different cytoskeletal elements interact, the nature of their dynamics 
in different compartments and how they respond to both internal and external stimuli, 
be it under physiological or pathological conditions. Finally, obtaining a better basic 
appreciation of the function of the cytoskeleton will assist in developing tailored 
strategies to combat disorders of the human nervous system.  
 We hope that this Special Issue will help to generate a unified picture of the 
different aspects of cytoskeletal structure and function in neurons, and will aid in 
developing integrative concepts to understand and modulate cytoskeletal function and 
malfunction in health and disease. 
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